IHG Genotech Symposium September 9, 2024 Agenda
Time | Who | Title | Talk Title | |
Introductions | 9:00-9:10 | Kathy Giacomini | Dean, School of Pharmacy, UCSF | |
9:10-9:15 | Nadav Ahituv | Director, Institute for Human Genetics, UCSF | ||
Gene Therapy | 9:15-9:35 | Christof Fellmann | Head of CRISPR-X, Executive Director, CRISPR Therapeutics | Translating gene editing to the clinic |
9:35-9:55 | David Schaffer | Professor, Director of QB3, Director of Bakar Labs, UC Berkeley | Directed Evolution of Novel Adeno-Associated Viral Vectors for Clinical Gene Therapy | |
9:55-10:25 | Francine Gregoire | Chief Scientific Officer, Addition Therapeutics | PRINTing the Future: How Retrotransposons Will Transform Genetic Medicine | |
10:25-10:45 | Kyle Cromer | Assistant Professor, Surgery, UCSF | Using human genetics to increase production of clinically relevant cell types | |
10:45-11:15 | Panel Discussion | |||
Break | 11:15-11:45 | |||
Keynote Speaker | 11:45-12:30 | Emil Kakkis | Founder, President and Chief Executive Officer, Ultragenyx | The development of treatments for rare diseases: the impact of genetic technologies to open the path to first-ever treatments |
Lunch & Career Panel | 12:30-1:45 | Christina Fan, Francine Gregorie, Emil Kakkis, and David Kelley |
|
|
AI | 1:45-2:05 | Andrew Carroll | Product Lead Genomics in Google Research | Deep Learning for Clinical Genetics and Cohort Genomics |
2:05-2:25 | David Kelley | Principal Investigator, Calico Life Sciences | Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation | |
2:25-2:45 | Danny Wells | Founder - Santa Ana Bio, Immunai | Lessons from the front lines of building platform biotherapeutics companies | |
2:45-3:05 | Tony Capra |
Professor, Epidemiology & Biostatistics and Bakar Computational Health Sciences Institute, UCSF |
AI as a time machine: predicting ancient and future phenotypes with sequence-based machine learning | |
3:05-3:25 | Panel Discussion | |||
Break | 3:25-3:55 | |||
Genomic Technologies |
3:55-4:15 | Christina Fan | Co-Founder and Chief Technology Officer, Curio Bioscience | Bringing spatial context to single-cell multiomic studies |
4:15-4:35 | Andrew Farmer | Chief Scientific Officer and Head of Research & Development, Takara Bio USA | Driving biomarker discovery with high-throughput single-cell genome and transcriptome profiling | |
4:35-4:55 | Wenjun Ouyang | Senior VP, Inflammation and Fibrosis, Data Science, Discovery Science & Technology, Gilead | Exploring Treg dynamics and identifying CCR8 as a therapeutic target by scRNAseq in human cancers and preclinical models | |
4:55-5:15 | Yin Shen | Professor, Neurology, UCSF | Characterizing Human Genome Function at Base Pair Resolution | |
5:15-5:45 | Panel Discussion | |||
Reception in Rock Hall room RH-502 | 6:00-7:00 |